194 related articles for article (PubMed ID: 29679610)
21. MITF, the Janus transcription factor of melanoma.
Koludrovic D; Davidson I
Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
[TBL] [Abstract][Full Text] [Related]
22. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
23. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
[TBL] [Abstract][Full Text] [Related]
24. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.
Pierrat MJ; Marsaud V; Mauviel A; Javelaud D
J Biol Chem; 2012 May; 287(22):17996-8004. PubMed ID: 22496449
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
[TBL] [Abstract][Full Text] [Related]
27. Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells.
Motzik A; Amir E; Erlich T; Wang J; Kim BG; Han JM; Kim JH; Nechushtan H; Guo M; Razin E; Tshori S
Oncogene; 2017 Aug; 36(33):4732-4738. PubMed ID: 28394346
[TBL] [Abstract][Full Text] [Related]
28. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
[TBL] [Abstract][Full Text] [Related]
29. The impact of MITF on melanoma development: news from bench and bedside.
Roider EM; Fisher DE
J Invest Dermatol; 2014 Jan; 134(1):16-17. PubMed ID: 24352080
[TBL] [Abstract][Full Text] [Related]
30. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
[TBL] [Abstract][Full Text] [Related]
31. MITF in melanoma: mechanisms behind its expression and activity.
Hartman ML; Czyz M
Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
33. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
[TBL] [Abstract][Full Text] [Related]
34. FBXW7 regulates a mitochondrial transcription program by modulating MITF.
Abbate F; Badal B; Mendelson K; Aydin IT; Serasinghe MN; Iqbal R; Mohammed JN; Solovyov A; Greenbaum BD; Chipuk JE; Celebi JT
Pigment Cell Melanoma Res; 2018 Sep; 31(5):636-640. PubMed ID: 29665239
[TBL] [Abstract][Full Text] [Related]
35. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
[TBL] [Abstract][Full Text] [Related]
36. Pathways from senescence to melanoma: focus on MITF sumoylation.
Leclerc J; Ballotti R; Bertolotto C
Oncogene; 2017 Nov; 36(48):6659-6667. PubMed ID: 28825724
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
Sestáková B; Ondrusová L; Vachtenheim J
Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
[TBL] [Abstract][Full Text] [Related]
38. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
39. MITF has a central role in regulating starvation-induced autophagy in melanoma.
Möller K; Sigurbjornsdottir S; Arnthorsson AO; Pogenberg V; Dilshat R; Fock V; Brynjolfsdottir SH; Bindesboll C; Bessadottir M; Ogmundsdottir HM; Simonsen A; Larue L; Wilmanns M; Thorsson V; Steingrimsson E; Ogmundsdottir MH
Sci Rep; 2019 Jan; 9(1):1055. PubMed ID: 30705290
[TBL] [Abstract][Full Text] [Related]
40.
Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]